The predictive value of CD38 positive hepatic stellate cell count for assessing disease activity and fibrosis in patients with chronic hepatitis

Acta Histochemica

Volumn 111, Issue 6, 2009, Pages 520-530

  Abdeen, Suad M ^a   Olusi, Samuel Olusoji ^a   Askar, Hifa A ^b   Thalib, Lukman ^a   Al Azemi, Aysha ^a   George, Sunila ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

Author keywords

CD38; Hepatic stellate cells; Liver fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD38 ANTIGEN;

ADULT; ANTIBODY LABELING; ARTICLE; AUTOIMMUNE HEPATITIS; CELL COUNT; CHRONIC HEPATITIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITO CELL; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METAVIR SCORING SYSTEM; NONALCOHOLIC FATTY LIVER; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STELLATE CELL;

ADULT; ANTIGENS, CD38; FEMALE; FIBROSIS; HEPATIC STELLATE CELLS; HEPATITIS, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

HEPATITIS C VIRUS;

EID: 70350618091     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.04.008     Document Type: Article

References (42)

1. Albanis E., and Friedman S.L. Hepatic fibrosis: pathogenesis and principles of therapy. Clin Liver Dis 5 (2001) 315-334 v-vi
2. Albert G., Camilla E., Toshiro N., Annemie W., Freja V., and Milos P. Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin. Hepatology 33 (2001) 177-188
3. Bataller R., Nicolas J.M., Ginees P., Gorbig M.N., Garcia-Ramallo E., Lario S., et al. Contraction of human hepatic stellate cells activated in culture: a role for voltage operated calcium channels. J Hepatol 29 (1998) 398-408
4. Bataller R., North K.E., and Bernner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (2003) 493-503
5. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
6. Bridle K.R., Crawford D.H., and Ramm G.A. Identification and characterization of the hepatic stellate cell transferring receptor. Am J Pathol 162 (2003) 1661-1667
7. Cassiman D., van Pelt J., De Vos R., Van Lommel F., Desmet V., Yap S.H., et al. Synaptophysin: a novel marker for human and rat hepatic stellate cells. Am J Pathol 155 (1999) 1831-1839
8. Cassiman D., Libbrecht L., Desmet V., Denef C., and Roskams T.J. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36 (2002) 200-209
9. Deaglio S., Vaisititi T., Aydin S., Ferrero E., and Malayasi F. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenic network underlying chronic lymphocytic leukemia. Blood 108 (2006) 1135-1144
10. de Leeuw A.M., McCarthy S.P., Geerts A., and Knook D.L. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 4 (1984) 392-403
11. Dranoff J.A., Ogawal M., Kruglov E.A., Gaca M.D., Sevigny J., Robson S.C., et al. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol 287 (2004) G417-G424
12. Efsen E., Bonacchi A., Pastacaldi S., Valente A.J., Wenzel U.O., Tosti Guerra C., et al. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 337 (2001) 713-721
13. Friedman S.L. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis; mechanisms and treatment strategies. N Engl J Med 328 (1993) 1828-1835
14. Friedman S.L. Liver fibrosis-from bench to bedside. J Hepatol 38 Suppl. 1 (2003) S38-S53
15. Geerts A., Niki T., Helllemans K., De Craemer D., Van Den B.K., Lazou J.M., et al. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology 27 (1998) 590-598
16. 2+ from the endoplasmic reticulum and an acidic store in the secretory granule area. J Cell Sci 119 (2006) 226-238
17. Gratromanolaki A., Stathopoulos G.P., Tsiobanon E., Papadimitrion C., et al. Combined role of tumour angiogenesis, BCl-2 and P53 expression in the prognosis of patients with colorectal carcinoma. Cancer 86 (1999) 1421-1430
18. Hellerbrand A., Wang S.C., Tsukamoto H., Brenner D.A., and Rippe R.A. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 24 (1996) 670-676
19. Higashida H., Hashii M., Yokoyama S., Hoshi N., Chen X.L., Egorova A., et al. Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase. Pharmacol Ther 90 (2001) 283-296
20. Horder M., and Rej R. Alanine transaminase. In: Bergmeyer H.U., Bergmeyer J., and Grassl M. (Eds). Methods of enzymatic analysis. 3rd ed. (1983), Weinheim, Verlag-Chemie 444-456
21. Howard M., Grimaldi J.C., Bazan J.F., Lund F.E., Santos-Argumedo L., Parkhouse R.M., et al. Formation and hydrolysis of cyclic ADP-ribose catalysed by lymphocyte antigen CD38. Science 262 (1993) 1056-1059
22. Hunt P.W., Deeks S.G., Bangsberg D.R., Moss A., Sinclair E., Liegler T., et al. The independent effect of drug resistance on T cell activation in HIV infection. AIDS 20 (2006) 691-699
23. Johnson J.D., and Misler S. Nicotinic acid-adenine dinucleotide phosphate sensitive calcium stores initiate insulin signaling in human beta cells. Proc Natl Acad Sci USA 99 (2002) 14566-14571
24. Jooske I., Tania R., Ronald F.M., Ton U.l., Louis C.P., Jan R.o., et al. Morphological characterization of portal myofibroblasts and hepatic stellate cells in the normal dog liver. Comp Hepatol 10 (2006) 1186/1476-5926-5-7
25. 2+] and insulin secretion. J Biol Chem 274 (1999) 1869-1872
26. Lee H.C. Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling. J Biol Chem 280 (2005) 33693-33696
27. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 31 (1999) 1120-1130
28. Milliano M.T., and Luxon B.A. Initial signaling of the fibronectin receptor (alpha 5 beta1 integrin) in hepatic stellate cells is independent of tyrosine phosphorylation. J Hepatol 39 (2003) 32-37
29. Nitou M., Ishikawa K., and Shiojiri N. Imunohistochemical analysis of development if desmin-positive hepatic stellate cells in mouse liver. J Anat 197 Pt 4 (2000) 635-646
30. Okamoto H., and Takasawa S. Recent advances in the Okamoto model: the CD38 cyclic ADP-ribose signal system and the regenerating gene portion (Reg)-Reg receptor system in beta-cells. Diabetes 51 (2002) S462-S473
31. Pinzani M., Milani S., De Franco R., Grappone C., Caligiuri A., Gentillini A., et al. Endothelin 1 is over expressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110 (1996) 534-548
32. Ramadori G., Viet T., Schwogler S., Dienes H.P., Knittel T., Rieder H., et al. Expression of the gene of the alpha smooth muscle-actin isoform in rat liver and in rat fat storing (ITO) cells. Virchow's Arch B Cell Pathol Incl Mol Pathol 59 (1990) 349-357
33. Regev A., Molina E., Moua R., Bejarano P., et al. Reliability of histopathologic assessment for differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transplant 10 (2004) 1233-1239
34. Reinherz E.L., Kung P.C., Goldstein G., Levey R.H., and Schlossman S.F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci 77 (1980) 1588-1592
35. Rej R., and Horder M. Aspartate aminotransferase. In: Bergmeyer H.U., Bergmeyer J., and Grassl M. (Eds). Methods of enzymatic analysis. 3rd ed. (1983), Verlag-Chemie, Weinheim 416-433
36. Sandra M., Mariona G., Maria R.S., Francisco L., Pilar P., Jaume B., et al. Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol 170 (2007) 176-187
37. Steiling H., Muhlbauer M., Bataille F., Scholmerich J., and Werner S. Heller brand C: activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease. Am J Pathol 165 (2004) 1233-1244
38. Takasawa S., Tohgo A., Noguchi N., Koguma T., Nata K., Sugimoto T., et al. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem (1993) 26052-26054
39. Tsutsumi M., Takada A., and Takase S. Characterization of desmin-positive rat liver sinusoidal cells. Hepatology 7 (1987) 277-284
40. 2+ signals in pancreatic acinar and beta cells. J Biol Chem 279 (2004) 7234-7240
41. Yang C., Zeisberg M., Mosterman B., Sudhakar A., Yerramalla U., Holthaus K., et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 124 (2003) 147-159
42. Zlobec I., Steele R., Michel R.P., Compton C.C., et al. Scoring of P53, VEGF, BCl-2 and APAF-1 immunohistochemistry and inter observer reliability in colorectal cancer. Mod Pathol 19 (2006) 1236-1242